Hélène Braun1, Clément Geniez1, Yannick Degboe1,2, Arnaud Constantin1,2, Alain Cantagrel1,2, Delphine Nigon1, Nicolas Sans3, Marie Faruch-Bilfeld3, Adeline Ruyssen-Witrand4,5. 1. Centre de rhumatologie, CHU de Toulouse, Université Paul Sabatier Toulouse III, 31059, Cedex 09, Toulouse, France. 2. UMR 1043, Inserm, Université Paul Sabatier Toulouse III, 31059, Cedex 09, Toulouse, France. 3. Centre de radiologie, CHU de Toulouse, Université Paul Sabatier Toulouse III, 31059, Cedex 09, Toulouse, France. 4. Centre de rhumatologie, CHU de Toulouse, Université Paul Sabatier Toulouse III, 31059, Cedex 09, Toulouse, France. adruyssen@hotmail.com. 5. UMR 1027, Inserm, Université Paul Sabatier Toulouse III, 1, place du Dr Baylac 31059, Cedex 09, Toulouse, France. adruyssen@hotmail.com.
Abstract
OBJECTIVES: This study was conducted in order to compare the prevalence of inflammatory posterior arch abnormalities on lumbar spine MRI between axial spondyloarthritis (axSpA) patients and low back pain (LBP) patients. METHODS: Patients-axSpA patients meeting the 2009 ASAS criteria and chronic LBP patients who had a lumbar spine MRI were selected. MRI-STIR and T1 sagittal images up to T8-T9 were reviewed by two experienced rheumatologists blinded to the diagnosis and clinical data to identify inflammatory posterior arch abnormalities. Analyses-The prevalence of inflammatory posterior arch abnormalities between axSpA and LBP patients was compared. Clinical data were compared in the axSpA group depending on whether or not inflammatory posterior arch abnormalities were present. RESULTS: Ninety-five patients were enrolled in each group. The prevalence of all inflammatory posterior arch abnormalities was the same in the axSpA and LBP groups (58% in the SpA group versus 70% in the LBP group, p = 0.1). However, differences in terms of the prevalence of costotransverse joint arthritis, pedicle oedema above L3 and transverse and spinous process oedema were observed between the two groups (axSpA 27% versus LBP 6%, p = 0.0004). Patients with inflammatory posterior arch abnormalities in the axSpA group had a longer disease duration (11 versus 8 years, p = 0.02), higher CRP levels (median 11 versus 3 mg/l, p = 0.0002) and higher prevalence of radiographic sacroiliitis (84 versus 47%, p = 0.001) compared to patients without inflammatory posterior arch abnormalities. CONCLUSIONS: Costotransverse arthritis, pedicle oedema and transverse process oedema are more frequent in axSpA patients than LBP patients, on lumbar spine MRI depicting TH9-S1. KEY POINTS: • MRI pedicle oedema above L3, transverse process oedema, spinous process oedema or costotransverse arthritis is more frequently observed in axial spondyloarthritis (SpA). • SpA patients with at least one MRI inflammatory lesion on the posterior arch had higher clinical activity scores and biological inflammation. • Facet joint arthritis was more common in patients with chronic low back pain.
OBJECTIVES: This study was conducted in order to compare the prevalence of inflammatory posterior arch abnormalities on lumbar spine MRI between axial spondyloarthritis (axSpA) patients and low back pain (LBP) patients. METHODS:Patients-axSpA patients meeting the 2009 ASAS criteria and chronic LBP patients who had a lumbar spine MRI were selected. MRI-STIR and T1 sagittal images up to T8-T9 were reviewed by two experienced rheumatologists blinded to the diagnosis and clinical data to identify inflammatory posterior arch abnormalities. Analyses-The prevalence of inflammatory posterior arch abnormalities between axSpA and LBP patients was compared. Clinical data were compared in the axSpA group depending on whether or not inflammatory posterior arch abnormalities were present. RESULTS: Ninety-five patients were enrolled in each group. The prevalence of all inflammatory posterior arch abnormalities was the same in the axSpA and LBP groups (58% in the SpA group versus 70% in the LBP group, p = 0.1). However, differences in terms of the prevalence of costotransverse joint arthritis, pedicle oedema above L3 and transverse and spinous process oedema were observed between the two groups (axSpA 27% versus LBP 6%, p = 0.0004). Patients with inflammatory posterior arch abnormalities in the axSpA group had a longer disease duration (11 versus 8 years, p = 0.02), higher CRP levels (median 11 versus 3 mg/l, p = 0.0002) and higher prevalence of radiographic sacroiliitis (84 versus 47%, p = 0.001) compared to patients without inflammatory posterior arch abnormalities. CONCLUSIONS: Costotransverse arthritis, pedicle oedema and transverse process oedema are more frequent in axSpA patients than LBP patients, on lumbar spine MRI depicting TH9-S1. KEY POINTS: • MRI pedicle oedema above L3, transverse process oedema, spinous process oedema or costotransverse arthritis is more frequently observed in axial spondyloarthritis (SpA). • SpA patients with at least one MRI inflammatory lesion on the posterior arch had higher clinical activity scores and biological inflammation. • Facet joint arthritis was more common in patients with chronic low back pain.
Entities:
Keywords:
Ankylosing; Diagnosis; Differential; Magnetic resonance imaging; Spondylitis
Authors: Christian E Althoff; Joachim Sieper; In-Ho Song; Hildrun Haibel; Anja Weiß; Torsten Diekhoff; Martin Rudwaleit; Bruce Freundlich; Bernd Hamm; Kay-Geert A Hermann Journal: Ann Rheum Dis Date: 2012-06-26 Impact factor: 19.103
Authors: Bodil Arnbak; Tue S Jensen; Niels Egund; Anna Zejden; Kim Hørslev-Petersen; Claus Manniche; Anne G Jurik Journal: Eur Radiol Date: 2015-07-22 Impact factor: 5.315
Authors: M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper Journal: Ann Rheum Dis Date: 2009-03-17 Impact factor: 19.103
Authors: Kay-Geert A Hermann; Xenofon Baraliakos; Désirée M F M van der Heijde; Anne-Grethe Jurik; Robert Landewé; Helena Marzo-Ortega; Mikkel Østergaard; Martin Rudwaleit; Joachim Sieper; Jürgen Braun Journal: Ann Rheum Dis Date: 2012-05-14 Impact factor: 19.103
Authors: Ulrich Weber; Christian W A Pfirrmann; Rudolf O Kissling; Juerg Hodler; Marco Zanetti Journal: BMC Musculoskelet Disord Date: 2007-02-27 Impact factor: 2.362
Authors: Désirée van der Heijde; Joachim Sieper; Walter P Maksymowych; Matthew A Brown; Robert G W Lambert; Suchitrita S Rathmann; Aileen L Pangan Journal: Arthritis Rheumatol Date: 2014-03 Impact factor: 10.995
Authors: Susanne J Pedersen; Mikkel Østergaard; Simon Krabbe; Inge J Sørensen; Bente Jensen; Jakob M Møller; Lone Balding; Ole R Madsen; Robert G W Lambert; Walter P Maksymowych Journal: RMD Open Date: 2018-03-16